Brief: Acadia Pharmaceuticals Q4 EPS USD 1.6
25/02/2026 21:05
Feb 25 (Reuters) - Acadia Pharmaceuticals Q4 operating expenses USD 266.598 million. Q4 product sales USD 283.989 million Q4 net income USD 273.568 million Q4 pretax profit USD 26.319 million
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry